Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin C Thomas

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Expert Opinion on Emerging Drugs|January 22, 2013
Emerging drugs for managing kidney disease in patients with diabetesMerlin C Thomas
Therapeutic Advances in Endocrinology and Metabolism|August 16, 2014
Renal effects of dapagliflozin in patients with type 2 diabetesMerlin C Thomas
Diabetes & Metabolism|April 23, 2017
The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetesMerlin C Thomas
Nature Clinical Practice. Nephrology|December 22, 2006
Anemia in diabetes: marker or mediator of microvascular disease?Merlin C Thomas
Current Cardiology Reviews|June 10, 2016
Type 2 Diabetes and Heart Failure: Challenges and SolutionsMerlin C Thomas
Seminars in Nephrology|September 5, 2006
The high prevalence of anemia in diabetes is linked to functional erythropoietin deficiencyMerlin C Thomas
Nephrology (Carlton, Vic.)|February 24, 2007
The CARI guidelines. Prevention of progression of kidney disease: early referral of patients with pre-end-stage kidney diseaseMerlin C Thomas,
Clinical Medicine Insights. Cardiology|June 15, 2018
<i>Perspective Review</i>: Type 2 Diabetes and Readmission for Heart FailureMerlin C Thomas
Diabetes Research and Clinical Practice|December 21, 2007
The assessment and management of albuminuria in primary careMerlin C Thomas
Current Diabetes Reports|February 25, 2016
Epigenetic Mechanisms in Diabetic Kidney DiseaseMerlin C Thomas
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Expert Opinion on Emerging Drugs|January 22, 2013
Emerging drugs for managing kidney disease in patients with diabetesMerlin C Thomas
Therapeutic Advances in Endocrinology and Metabolism|August 16, 2014
Renal effects of dapagliflozin in patients with type 2 diabetesMerlin C Thomas
Diabetes & Metabolism|April 23, 2017
The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetesMerlin C Thomas
Nature Clinical Practice. Nephrology|December 22, 2006
Anemia in diabetes: marker or mediator of microvascular disease?Merlin C Thomas
Current Cardiology Reviews|June 10, 2016
Type 2 Diabetes and Heart Failure: Challenges and SolutionsMerlin C Thomas
Seminars in Nephrology|September 5, 2006
The high prevalence of anemia in diabetes is linked to functional erythropoietin deficiencyMerlin C Thomas
Nephrology (Carlton, Vic.)|February 24, 2007
The CARI guidelines. Prevention of progression of kidney disease: early referral of patients with pre-end-stage kidney diseaseMerlin C Thomas,
Clinical Medicine Insights. Cardiology|June 15, 2018
<i>Perspective Review</i>: Type 2 Diabetes and Readmission for Heart FailureMerlin C Thomas
Diabetes Research and Clinical Practice|December 21, 2007
The assessment and management of albuminuria in primary careMerlin C Thomas
Current Diabetes Reports|February 25, 2016
Epigenetic Mechanisms in Diabetic Kidney DiseaseMerlin C Thomas
Pageof 18